­
← Older posts

Columbia Personal Injury Lawyers: Breast Implants and Lymphoma


The FDA is warning physicians and women of a link between breast implants and a rare form of cancer. Anaplastic Large Cell Lymphoma (“ALCL”) is a type of T-cell lymphoma that can be particularly aggressive. Fortunately only about 600 women in the United States contract this cancer each year, but recent studies have shown that » Read More

Lexington County Personal Injury Lawyers discuss Chemotherapy and Permanent Baldness: Why Lawsuits are Emerging


Chemotherapy and Permanent Baldness: Why Lawsuits are Emerging Alopecia—hair loss—is a common side effect of chemotherapy. Permanent alopecia is not. Typically, a chemotherapy patient’s hair will fully regrow within 6 months of the end of treatment. In very rare circumstances (less than 1%), however, the intense drug regimen can permanently damage hair follicles, resulting in » Read More

Richland County Personal Injury Lawyers discuss IVC Filters: Case Screening


Blood clots are a common—and potentially fatal—condition associated with significant trauma and a variety of surgeries and medical treatments. Typically forming in the legs, clots have the ability to travel to your lungs, plugging vital vessels in those organs and resulting in a pulmonary embolism. One-third of people with untreated pulmonary embolisms do not survive. » Read More

Talc and Ovarian Cancer Update: Heading to New Jersey


Talc and Ovarian Cancer Update: Heading to New Jersey A judicial panel has consolidated all federal talcum powder/ovarian cancer litigation in the District of New Jersey, joining sixty-six cases and what promises to be hundreds (if not thousands) more.  The order creates what is known as an “MDL” (multidistrict litigation) court in which single federal » Read More

Dangerous Drug News: FDA Strengthens Warnings for Levaquin Antibiotics


FDA Strengthens Warnings for Levaquin Antibiotics A certain class of antibiotics used to treat serious bacterial infections has recently become the focus of a strong public warning issued by regulators at the U.S. Food and Drug Administration (FDA). These antibiotics – known as fluoroquinolones and sold under various brand names (including Levaquin) – have been » Read More

The Big Lie: Johnson & Johnson, Talc, and Ovarian Cancer


The Big Lie: Johnson & Johnson, Talc, and Ovarian Cancer In the aftermath of verdicts of $72 million and $55 million on behalf of ovarian cancer victims, Johnson & Johnson is fighting back by releasing a public statement which misleads women about the connection between perineal use of talcum powder and ovarian cancer. Here, we » Read More

Starbucks’ Teavana Ordered to Pay $3.75 Million Penalty for Exploding Tumblers, CPSC Announces


Teavana to Pay $3.75M Fine for Exploding Tumblers Teavana, a tea retailer purchased by Starbucks’ in 2012, has recently been hit with a hefty civil penalty for its role in failing to report major defects associated with its glass tumblers to federal authorities. According to regulators at the Consumer Product Safety Commission (CPSC), Teavana “knowingly » Read More

FDA Issues New Safety Alert for Popular Antibiotics: ‘Fluoroquinolones’ Risks Don’t Outweigh Benefits for Some Patients,’ Regulators Announce


FDA Issues New Safety Alert for Popular Antibiotics Yesterday, regulators at the U.S. Food and Drug Administration (FDA) issued a new safety alert, urging medical professionals to limit their use of certain popular antibiotics – fluoroquinolone antibacterial drugs – for some patients. According to this warning, regulators have discovered a link between the use of » Read More

Takata Airbag Recall News: NHTSA Announces Plans to Expand & Accelerate the Recall


NHTSA Announces an Expansion of the Takata Airbag Recall Regulators at the National Highway Traffic Safety Administration (NHTSA) have just announced that all Takata airbags that have frontal inflators lacking a chemical drying agent are now subject to the recall. This expansion of an already massive recall effort will reportedly impact at least 35 million » Read More

Ovarian Cancer and Baby Powder: J&J Hammered Again


Ovarian Cancer and Baby Powder: J&J Hammered Again A Missouri jury has returned a verdict of $55 million on behalf of a woman who contracted ovarian cancer as a result of her use of Johnson & Johnson’s baby powder. This verdict comes two months after a $72 million verdict on behalf of another cancer victim. » Read More

← Older posts